Patents by Inventor Evan Thompson

Evan Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240175812
    Abstract: A scattered light polarimetry (LSP) sub-system of a hybrid system for characterizing stress in a chemically-strengthened (CS) substrate having a top-surface and a near-surface waveguide, includes a LSP light source system, an LSP light source actuator coupled to the LSP light source system, and an optical compensator within an optical path of a LSP laser beam emitted by the LSP light source system. The optical compensator includes a half-wave plate, a half-wave plate actuator, a diffuser, and a diffuser actuator. The LSP sub-system further includes a LSP detector system in optical communication with the optical compensator through an LSP coupling prism having a LSP coupling surface, a focusing lens and a focusing lens actuator, and a support plenum having a surface and a measurement aperture, the support plenum configured to support the CS substrate at a measurement plane at the measurement aperture, and to operably support the LSP coupling prism.
    Type: Application
    Filed: November 28, 2023
    Publication date: May 30, 2024
    Inventors: Ryan Claude Andrews, David Matthew Berg, Pierre Michel Bouzi, William John Furnas, Christopher David Gee, Jacob Immerman, Andrew Allen Lindstrand, Glenn Abram Newcomer, Evan Lewis Olson, Melbourne Thompson Turnbull, IV, Nathaniel David Wetmore
  • Publication number: 20240174754
    Abstract: The disclosure relates to antibodies, or antigen-binding fragments thereof, that specifically bind to killer cell lectin-like receptor G1 (KLRG1). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes, including treatment of cancers and to increase the effectiveness of vaccines.
    Type: Application
    Filed: March 25, 2022
    Publication date: May 30, 2024
    Inventors: Stefano V. GULLA, Kenneth Evan THOMPSON
  • Patent number: 11989394
    Abstract: Devices, methods and graphical user interfaces for manipulating user interfaces based on fingerprint sensor inputs are provided. While a display of an electronic device with a fingerprint sensor displays a first user interface, the device may detect movement of a fingerprint on the fingerprint sensor. In accordance with a determination that the movement of the fingerprint is in a first direction, the device allows navigating through the first user interface, and in accordance with a determination that the movement of the fingerprint is in a second direction different from the first direction, the device allows displaying a second user interface different from the first user interface on the display.
    Type: Grant
    Filed: November 12, 2021
    Date of Patent: May 21, 2024
    Assignee: Apple Inc.
    Inventors: Benjamin J. Pope, Daniel W. Jarvis, Nicholas G. Merz, Scott A. Myers, Michael A. Cretella, Michael Eng, James H. Foster, Terry L. Gilton, Myra Haggerty, Byron B. Han, M. Evans Hankey, Steven P. Hotelling, Brian R. Land, Stephen Brian Lynch, Paul Meade, Mushtaq A. Sarwar, John P. Ternus, Paul M. Thompson, Marcel Van Os, John A. Wright
  • Patent number: 11980709
    Abstract: A fat harvesting systems and related methods of harvesting and reinjecting fat that provides a medical professional with multiple technique options. Harvested fat can be subjected to a variety of pre-reinjection preparation steps within a single, self contained reservoir such that the potential for contaminating the harvested fat is avoided. The fat harvesting system can be completely self-contained kit requiring no additional external systems or alternatively, can utilize available surgical suite systems, for example, vacuum to successfully harvest, prepare and reinject fat cells. The fat harvesting system can size harvested fat cells so as to be especially desirable for different injection locations in the body. The fat harvesting system is a single use, disposable system that requires no sterilization equipment and recovered and sized fat cells are maintained in a sanitary environment so as to avoid contamination that could result in having to discard recovered fat cells.
    Type: Grant
    Filed: May 5, 2023
    Date of Patent: May 14, 2024
    Assignee: Chopra Gryskiewicz, LLC
    Inventors: Karan Chopra, Joseph M. Gryskiewicz, Richard A. Thompson, Reed O. Saunders, Evan M. Leingang, Thomas A. Tedham, Mohamed A. Mohamed, Jacob T. Wilson, Brett J. Herdegen, Jason N. Scherer, Landon Hove Dinger, Justin A. Barbot
  • Publication number: 20240107229
    Abstract: A smart speaker power controller may be configured to receive power conforming to one of a plurality of power modes from an input power source. The power controller may be further configured to communicate the power mode to at least one component of a processing system or at least one component of an audio system for operating the smart speaker according to the received power mode, including determining a current limit of a power converter; determining a shutdown voltage threshold and safely shutting down the smart speaker if the input voltage falls below the threshold, and/or modifying audio operation of the smart speaker in response to the power mode. The smart speaker can further include an audio power supply controller configured to monitor energy required to reproduce an audio signal and to servo a power supply voltage provided to an audio amplifier in response to this energy level.
    Type: Application
    Filed: December 11, 2023
    Publication date: March 28, 2024
    Inventors: Zhigang Dang, Daniel Naito, Evan Thompson, Peter Poon, Manasi Lagare, Michael Nussbaum, David Sumberg
  • Publication number: 20240090748
    Abstract: A system includes an endoscope connector and an endoscope adapter. The endoscope connector includes a first portion. The first portion includes a first magnetic coupling element and a first planar portion that is perpendicular to an axial direction of the endoscope connector. The endoscope adapter includes a second planar portion. The second planar portion includes a second magnetic coupling element and a substantially planar surface that is perpendicular to an axial direction of the endoscope adapter. The endoscope connector is non-mechanically attachable to the endoscope adapter using the first magnetic coupling element and the second magnetic coupling element. The first planar portion is alignable with the second planar portion such that: electroconductive contacts of the endoscope connector are axially aligned with electroconductive pins of the endoscope adapter and a port of the endoscope connector is axially aligned with a corresponding insertion port of the endoscope adapter.
    Type: Application
    Filed: November 27, 2023
    Publication date: March 21, 2024
    Inventors: Anina COOTER, Michael KLOTER, Evan M. LEINGANG, Kevin R. LOCHNER, Indrek-Toomas POLLUKS, Marko RADOSEVIC, Jeremy ROTH, Reed O. SAUNDERS, Thomas A. TEDHAM, Richard A. THOMPSON, II, Chase VAN ROSSEN
  • Patent number: 11910171
    Abstract: A smart speaker power controller may be configured to receive power conforming to one of a plurality of power modes from an input power source. The power controller may be further configured to communicate the power mode to at least one component of a processing system or at least one component of an audio system for operating the smart speaker according to the received power mode, including determining a current limit of a power converter; determining a shutdown voltage threshold and safely shutting down the smart speaker if the input voltage falls below the threshold, and/or modifying audio operation of the smart speaker in response to the power mode. The smart speaker can further include an audio power supply controller configured to monitor energy required to reproduce an audio signal and to servo a power supply voltage provided to an audio amplifier in response to this energy level.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: February 20, 2024
    Assignee: Apple Inc.
    Inventors: Zhigang Dang, Daniel Naito, Evan Thompson, Peter Poon, Manasi Lagare, Michael Nussbaum, David Sumberg
  • Patent number: 11339222
    Abstract: A method of treating a subject can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent, thereby disrupting KLRG1 signaling and activating CD8+ cytotoxic T and/or NK cells. A method of treating cancer can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent. The methods can treat various cancers, for example melanoma, lung cancer, pancreatic cancer, glioma, breast cancer, and ovarian cancer.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: May 24, 2022
    Assignee: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
  • Publication number: 20220089747
    Abstract: The receptor killer cell lectin-like receptor G1 (KLRG1) is expressed on T and NK cells, which binds to ligands on epithelial and mesenchymal cells. The ligand for KLRG1 has been described to be E-cadherin, N-cadherin, and R-cadherin. The present disclosure relates to and results from the discovery and characterization of antibodies that bind the extracellular domain (ECD) of KLRG1 but do not interfere with its interaction with the ligands E-cadherin, N-cadherin, and R-cadherin. The antibodies described have been derived by mouse hybridoma technology, and can be humanized by grafting their complementary determining regions (CDRs) into a human framework. The antibodies described can be used as effective therapeutic agents. Various antibodies, or antigen-binding fragments of such antibodies, along with various therapeutic and/or diagnostic methods, among other features, are provided for in the present disclosure.
    Type: Application
    Filed: October 20, 2021
    Publication date: March 24, 2022
    Inventors: Stefano Vincenzo Gulla, Kenneth Evan Thompson
  • Publication number: 20220078548
    Abstract: A smart speaker power controller may be configured to receive power conforming to one of a plurality of power modes from an input power source. The power controller may be further configured to communicate the power mode to at least one component of a processing system or at least one component of an audio system for operating the smart speaker according to the received power mode, including determining a current limit of a power converter; determining a shutdown voltage threshold and safely shutting down the smart speaker if the input voltage falls below the threshold, and/or modifying audio operation of the smart speaker in response to the power mode. The smart speaker can further include an audio power supply controller configured to monitor energy required to reproduce an audio signal and to servo a power supply voltage provided to an audio amplifier in response to this energy level.
    Type: Application
    Filed: December 4, 2020
    Publication date: March 10, 2022
    Inventors: Zhigang Dang, Daniel Naito, Evan Thompson, Peter Poon, Manasi Lagare, Michael Nussbaum, David Sumberg
  • Patent number: 11180561
    Abstract: The receptor killer cell lectin-like receptor G1 (KLRG1) is expressed on T and NK cells, which binds to ligands on epithelial and mesenchymal cells. The ligand for KLRG1 has been described to be E-cadherin, N-cadherin, and R-cadherin. The present disclosure relates to and results from the discovery and characterization of antibodies that bind the extracellular domain (ECD) of KLRG1 but do not interfere with its interaction with the ligands E-cadherin, N-cadherin, and R-cadherin. The antibodies described have been derived by mouse hybridoma technology, and can be humanized by grafting their complementary determining regions (CDRs) into a human framework. The antibodies described can be used as effective therapeutic agents. Various antibodies, or antigen-binding fragments of such antibodies, along with various therapeutic and/or diagnostic methods, among other features, are provided for in the present disclosure.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: November 23, 2021
    Assignee: Abcuro, Inc.
    Inventors: Stefano Vincenzo Gulla, Kenneth Evan Thompson
  • Publication number: 20210347899
    Abstract: The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to killer cell lectin-like receptor G1 (KLRG1). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes including treatment of cancers and to increase the effectiveness of vaccines.
    Type: Application
    Filed: September 6, 2019
    Publication date: November 11, 2021
    Inventors: Stefano V GULLA, Kenneth Evan THOMPSON
  • Publication number: 20190292264
    Abstract: A method of treating a subject can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent, thereby disrupting KLRG1 signaling and activating CD8+ cytotoxic T and/or NK cells. A method of treating cancer can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent. The methods can treat various cancers, for example melanoma, lung cancer, pancreatic cancer, glioma, breast cancer, and ovarian cancer.
    Type: Application
    Filed: June 2, 2017
    Publication date: September 26, 2019
    Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
  • Patent number: 10406545
    Abstract: A fluid delivery system for dispensing fluid can include a dispenser, such as a trigger engine-type dispenser, configured to draw fluid up from a container. A nozzle assembly can include a nozzle, and a nozzle slide. The nozzle slide can be configured to slide and/or rotate relative to the shroud to provide different dispensing modes. In alternative examples, the nozzle can be configured to rotate in 30 degree increments relative to the shroud to provide the different dispensing modes or the nozzle assembly can include a nozzle extension, and the nozzle extension can be configured to rotate relative to the shroud to provide different dispensing patterns out of the nozzle. In another example a first nozzle can be configured to provide one or more dispensing modes, and a second nozzle can be configured to provide a different dispensing mode than the first nozzle. Methods of dispensing fluids and methods of assembling fluid dispensers are also disclosed.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: September 10, 2019
    Assignee: S. C. Johnson & Son, Inc.
    Inventors: Ronald H. Spang, Jr., Matthew T. Mcdonnell, David Leifheit, Cory J. Nelson, Matthew Thurin, Philip Anthony, III, Aaron Eiger, Evan Thompson, Douglas A. Soller
  • Patent number: 10410513
    Abstract: A motor vehicle system for generating and transmitting motor vehicle imaging object data includes a communication system module positioned in a host vehicle receiving vehicle attribute data during host vehicle highway travel and preparing a fused object attribute data for transmission. An imaging device collects object imaging data representing objects within a visible detection range of the imaging device. An object detection and classification system module has an object classification sub-module used to classify the objects within the visible detection range as a vehicle type or a pedestrian and to output each as an object attribute data. A target fusion module receives the object attribute data from the object detection and classification system module, fuses the object attribute data with the vehicle attribute data to create the fused object attribute data, and forwards the fused object attribute data to the communication system module for transmission.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: September 10, 2019
    Assignee: DURA OPERATING, LLC
    Inventors: Donald Raymond Gignac, Aaron Evans Thompson, Danish Uzair Siddiqui, Rajashekhar Patil, Gordon M. Thomas
  • Publication number: 20190194333
    Abstract: A method of treating a subject can comprise administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1) depleting agent, thereby depleting CD8+ cytotoxic T and/or NK cells in vivo. A method of treating a subject can comprise administering to a subject in need thereof an effective amount of a KLRG1 depleting agent with effector killing function. A composition, for example an anti-KLRG1 antibody, can comprise a KLRG1 depleting agent. The methods and compositions can be used for various diseases in which KLRG1 is overexpressed, for example autoimmune diseases, transplant rejection, hematologic malignancies, and solid tumors.
    Type: Application
    Filed: September 15, 2017
    Publication date: June 27, 2019
    Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
  • Patent number: 10282997
    Abstract: A method of generating and communicating lane information from a host vehicle to a vehicle-to-vehicle (V2V) network includes collecting visual data from a camera, detecting a lane within the visual data, generating a lane classification for the lane based on the visual data, assigning a confidence level to the lane classification, generating a lane distance estimate from the visual data, generating a lane model from the lane classification and the lane distance estimate, and transmitting the lane model and the confidence level to the V2V network.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: May 7, 2019
    Assignee: DURA OPERATING, LLC
    Inventors: Donald Raymond Gignac, Aaron Evans Thompson, Danish Uzair Siddiqui, Rajashekhar Patil, Gordon M. Thomas
  • Publication number: 20190085083
    Abstract: A method of treating a subject can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent, thereby disrupting KLRG1 signaling and activating CD8+ cytotoxic T and/or NK cells. A method of treating cancer can include administering to a subject in need thereof an effective amount of a killer cell lectin-like receptor G1 (KLRG1)/ligand binding agent. The methods can treat various cancers, for example melanoma, lung cancer, pancreatic cancer, glioma, breast cancer, ovarian cancer, metastatic breast cancer, and colon cancer.
    Type: Application
    Filed: November 28, 2018
    Publication date: March 21, 2019
    Inventors: Steven Greenberg, Stefano Vincenzo Gulla, Kenneth Evan Thompson
  • Patent number: 10053010
    Abstract: A system for displaying an image on a display device of a motor vehicle includes a rear-view camera connected to a moveable component on the motor vehicle and a controller in communication with the rear-view camera. The controller has memory for storing control logic and a processor configured to execute the control logic. The control logic includes capturing a field of view image from the rear-view camera, determining a position of the rear-view camera, determining an image perspective relationship of the field of view image based on the position of the rear-view camera, modifying the field of view image based on the image perspective relationship to create a virtual perspective image, and displaying the virtual perspective image on the display device in the motor vehicle as the position of the rear-view camera changes between at least a first position and a second position.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: August 21, 2018
    Assignee: DURA OPERATING, LLC
    Inventors: Aaron Evans Thompson, Benjamin Saltsman, Sean O'Rourke
  • Patent number: 9959765
    Abstract: A motor vehicle alert system based on vehicle dynamics input includes a communication module positioned in a host vehicle receiving and sending vehicle data in a vehicle mobility data format. A list generator in communication with the communication module generates the vehicle data as specific vehicle identification data in a track list to distinguish a sensed vehicle and at least one other vehicle positioned proximate the host vehicle. A tracker module in communication with the list generator periodically updates the vehicle data for the sensed vehicle and the at least one other vehicle. A transient condition data device generates data identifying when a transient condition of the sensed vehicle is present. A message standard conformance module receives the data identifying the transient condition and forwards the data identifying the transient condition to the communication module for transmission to the at least one other vehicle proximate to the host vehicle.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: May 1, 2018
    Assignee: DURA OPERATING LLC
    Inventors: Aaron Evans Thompson, Donald Raymond Gignac, Danish Uzair Siddiqui, Rajashekhar Patil, Gordon M. Thomas